Comparison Overview

Thermo Fisher Scientific

VS

Genentech

Thermo Fisher Scientific

168 Third Avenue, Waltham, MA, undefined, US
Last Update: 2025-12-18
Between 800 and 849

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 97,914
Subsidiaries: 18
12-month incidents
0
Known data breaches
1
Attack type number
1

Genentech

1 Dna Way, South San Francisco, California, 94080, US
Last Update: 2025-12-17
Between 750 and 799

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation and diverse community around the issues we are passionate about. To that end, we remove profanity, content that contains credible threats or hate speech, content that is aimed at private individuals, personal information meant to harass someone, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 17,817
Subsidiaries: 50
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/thermo-fisher-scientific.jpeg
Thermo Fisher Scientific
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/genentech.jpeg
Genentech
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Thermo Fisher Scientific
100%
Compliance Rate
0/4 Standards Verified
Genentech
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Thermo Fisher Scientific in 2025.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Genentech in 2025.

Incident History — Thermo Fisher Scientific (X = Date, Y = Severity)

Thermo Fisher Scientific cyber incidents detection timeline including parent company and subsidiaries

Incident History — Genentech (X = Date, Y = Severity)

Genentech cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/thermo-fisher-scientific.jpeg
Thermo Fisher Scientific
Incidents

Date Detected: 7/2017
Type:Breach
Attack Vector: Email Compromise
Blog: Blog
https://images.rankiteo.com/companyimages/genentech.jpeg
Genentech
Incidents

No Incident

FAQ

Thermo Fisher Scientific company demonstrates a stronger AI Cybersecurity Score compared to Genentech company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Thermo Fisher Scientific company has historically faced a number of disclosed cyber incidents, whereas Genentech company has not reported any.

In the current year, Genentech company and Thermo Fisher Scientific company have not reported any cyber incidents.

Neither Genentech company nor Thermo Fisher Scientific company has reported experiencing a ransomware attack publicly.

Thermo Fisher Scientific company has disclosed at least one data breach, while the other Genentech company has not reported such incidents publicly.

Neither Genentech company nor Thermo Fisher Scientific company has reported experiencing targeted cyberattacks publicly.

Neither Thermo Fisher Scientific company nor Genentech company has reported experiencing or disclosing vulnerabilities publicly.

Neither Thermo Fisher Scientific nor Genentech holds any compliance certifications.

Neither company holds any compliance certifications.

Genentech company has more subsidiaries worldwide compared to Thermo Fisher Scientific company.

Thermo Fisher Scientific company employs more people globally than Genentech company, reflecting its scale as a Biotechnology Research.

Neither Thermo Fisher Scientific nor Genentech holds SOC 2 Type 1 certification.

Neither Thermo Fisher Scientific nor Genentech holds SOC 2 Type 2 certification.

Neither Thermo Fisher Scientific nor Genentech holds ISO 27001 certification.

Neither Thermo Fisher Scientific nor Genentech holds PCI DSS certification.

Neither Thermo Fisher Scientific nor Genentech holds HIPAA certification.

Neither Thermo Fisher Scientific nor Genentech holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

n8n is an open source workflow automation platform. Versions starting with 0.211.0 and prior to 1.120.4, 1.121.1, and 1.122.0 contain a critical Remote Code Execution (RCE) vulnerability in their workflow expression evaluation system. Under certain conditions, expressions supplied by authenticated users during workflow configuration may be evaluated in an execution context that is not sufficiently isolated from the underlying runtime. An authenticated attacker could abuse this behavior to execute arbitrary code with the privileges of the n8n process. Successful exploitation may lead to full compromise of the affected instance, including unauthorized access to sensitive data, modification of workflows, and execution of system-level operations. This issue has been fixed in versions 1.120.4, 1.121.1, and 1.122.0. Users are strongly advised to upgrade to a patched version, which introduces additional safeguards to restrict expression evaluation. If upgrading is not immediately possible, administrators should consider the following temporary mitigations: Limit workflow creation and editing permissions to fully trusted users only; and/or deploy n8n in a hardened environment with restricted operating system privileges and network access to reduce the impact of potential exploitation. These workarounds do not fully eliminate the risk and should only be used as short-term measures.

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

FastAPI Users allows users to quickly add a registration and authentication system to their FastAPI project. Prior to version 15.0.2, the OAuth login state tokens are completely stateless and carry no per-request entropy or any data that could link them to the session that initiated the OAuth flow. `generate_state_token()` is always called with an empty `state_data` dict, so the resulting JWT only contains the fixed audience claim plus an expiration timestamp. On callback, the library merely checks that the JWT verifies under `state_secret` and is unexpired; there is no attempt to match the state value to the browser that initiated the OAuth request, no correlation cookie, and no server-side cache. Any attacker can hit `/authorize`, capture the server-generated state, finish the upstream OAuth flow with their own provider account, and then trick a victim into loading `.../callback?code=<attacker_code>&state=<attacker_state>`. Because the state JWT is valid for any client for \~1 hour, the victim’s browser will complete the flow. This leads to login CSRF. Depending on the app’s logic, the login CSRF can lead to an account takeover of the victim account or to the victim user getting logged in to the attacker's account. Version 15.0.2 contains a patch for the issue.

Risk Information
cvss3
Base: 5.9
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:L/A:N
Description

FileZilla Client 3.63.1 contains a DLL hijacking vulnerability that allows attackers to execute malicious code by placing a crafted TextShaping.dll in the application directory. Attackers can generate a reverse shell payload using msfvenom and replace the missing DLL to achieve remote code execution when the application launches.

Risk Information
cvss3
Base: 9.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 8.5
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

LDAP Tool Box Self Service Password 1.5.2 contains a password reset vulnerability that allows attackers to manipulate HTTP Host headers during token generation. Attackers can craft malicious password reset requests that generate tokens sent to a controlled server, enabling potential account takeover by intercepting and using stolen reset tokens.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
cvss4
Base: 8.6
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Kimai 1.30.10 contains a SameSite cookie vulnerability that allows attackers to steal user session cookies through malicious exploitation. Attackers can trick victims into executing a crafted PHP script that captures and writes session cookie information to a file, enabling potential session hijacking.

Risk Information
cvss3
Base: 9.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 8.5
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X